Korro Bio (KRRO) Competitors $42.15 -6.45 (-13.27%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$42.06 -0.09 (-0.23%) As of 10/17/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KRRO vs. VCEL, JANX, EWTX, RCUS, HRMY, AUPH, PAHC, SDGR, HROW, and SNDXShould you be buying Korro Bio stock or one of its competitors? The main competitors of Korro Bio include Vericel (VCEL), Janux Therapeutics (JANX), Edgewise Therapeutics (EWTX), Arcus Biosciences (RCUS), Harmony Biosciences (HRMY), Aurinia Pharmaceuticals (AUPH), Phibro Animal Health (PAHC), Schrodinger (SDGR), Harrow (HROW), and Syndax Pharmaceuticals (SNDX). These companies are all part of the "pharmaceutical products" industry. Korro Bio vs. Its Competitors Vericel Janux Therapeutics Edgewise Therapeutics Arcus Biosciences Harmony Biosciences Aurinia Pharmaceuticals Phibro Animal Health Schrodinger Harrow Syndax Pharmaceuticals Vericel (NASDAQ:VCEL) and Korro Bio (NASDAQ:KRRO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations. Which has more risk and volatility, VCEL or KRRO? Vericel has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500. Comparatively, Korro Bio has a beta of 2.89, indicating that its stock price is 189% more volatile than the S&P 500. Which has higher earnings & valuation, VCEL or KRRO? Vericel has higher revenue and earnings than Korro Bio. Korro Bio is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVericel$237.22M7.51$10.36M$0.12294.33Korro Bio$2.27M174.36-$83.58M-$9.75-4.32 Does the media refer more to VCEL or KRRO? In the previous week, Vericel had 12 more articles in the media than Korro Bio. MarketBeat recorded 15 mentions for Vericel and 3 mentions for Korro Bio. Korro Bio's average media sentiment score of 0.42 beat Vericel's score of 0.36 indicating that Korro Bio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vericel 3 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Korro Bio 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in VCEL or KRRO? 13.2% of Korro Bio shares are owned by institutional investors. 7.2% of Vericel shares are owned by company insiders. Comparatively, 4.6% of Korro Bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is VCEL or KRRO more profitable? Vericel has a net margin of 2.85% compared to Korro Bio's net margin of 0.00%. Vericel's return on equity of 2.47% beat Korro Bio's return on equity.Company Net Margins Return on Equity Return on Assets Vericel2.85% 2.47% 1.69% Korro Bio N/A -61.51%-42.87% Do analysts recommend VCEL or KRRO? Vericel presently has a consensus target price of $58.40, indicating a potential upside of 65.35%. Korro Bio has a consensus target price of $86.83, indicating a potential upside of 106.01%. Given Korro Bio's stronger consensus rating and higher probable upside, analysts clearly believe Korro Bio is more favorable than Vericel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vericel 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.71Korro Bio 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.00 SummaryVericel beats Korro Bio on 9 of the 17 factors compared between the two stocks. Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KRRO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRRO vs. The Competition Export to ExcelMetricKorro BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$395.79M$2.62B$6.13B$10.55BDividend YieldN/A57.79%5.72%4.83%P/E Ratio-4.3223.3185.7827.06Price / Sales174.36778.09612.92132.30Price / CashN/A27.2425.8230.35Price / Book2.465.3212.226.58Net Income-$83.58M$33.06M$3.33B$276.84M7 Day Performance-7.79%-0.91%0.67%-0.72%1 Month Performance16.92%7.35%6.88%2.16%1 Year Performance-47.34%-5.13%58.88%34.63% Korro Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRROKorro Bio2.2333 of 5 stars$42.15-13.3%$86.83+106.0%-47.3%$395.79M$2.27M-4.3270Positive NewsVCELVericel3.34 of 5 stars$33.49+5.1%$60.40+80.4%-15.2%$1.61B$237.22M279.11300News CoverageAnalyst UpgradeAnalyst RevisionJANXJanux Therapeutics2.6612 of 5 stars$26.29-0.8%$78.31+197.9%-46.5%$1.59B$10.59M-14.6130EWTXEdgewise Therapeutics3.132 of 5 stars$14.71-2.6%$38.83+164.0%-57.7%$1.59BN/A-9.4960RCUSArcus Biosciences2.3976 of 5 stars$16.64+14.0%$26.78+61.0%-10.6%$1.55B$258M-5.25500Gap UpHRMYHarmony Biosciences4.7611 of 5 stars$26.36-0.7%$46.11+74.9%-26.9%$1.53B$714.73M8.50200Analyst ForecastAUPHAurinia Pharmaceuticals2.8523 of 5 stars$11.10-1.5%$13.00+17.1%+64.3%$1.48B$235.13M25.81300Positive NewsPAHCPhibro Animal Health3.8793 of 5 stars$36.58+0.5%$28.40-22.4%+65.0%$1.48B$1.30B31.002,475SDGRSchrodinger3.5947 of 5 stars$19.70+3.2%$26.29+33.4%+8.5%$1.40B$207.54M-7.94790News CoverageAnalyst ForecastHROWHarrow2.9772 of 5 stars$38.77+3.4%$68.50+76.7%-30.4%$1.39B$199.61M-155.08180Positive NewsGap DownSNDXSyndax Pharmaceuticals4.0138 of 5 stars$15.20-5.4%$39.22+158.0%-27.4%$1.38B$23.68M-3.91110Trending NewsAnalyst Revision Related Companies and Tools Related Companies Vericel Alternatives Janux Therapeutics Alternatives Edgewise Therapeutics Alternatives Arcus Biosciences Alternatives Harmony Biosciences Alternatives Aurinia Pharmaceuticals Alternatives Phibro Animal Health Alternatives Schrodinger Alternatives Harrow Alternatives Syndax Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KRRO) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
